Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078931 | SCV000110791 | other | not provided | 2018-07-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000249834 | SCV000304453 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000020310 | SCV000439433 | benign | Metachromatic leukodystrophy | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000078931 | SCV000511542 | benign | not provided | 2016-10-11 | criteria provided, single submitter | clinical testing | |
SIB Swiss Institute of Bioinformatics | RCV000020310 | SCV000883252 | benign | Metachromatic leukodystrophy | 2018-10-15 | criteria provided, single submitter | curation | This variant is interpreted as Benign - Stand Alone, for Metachromatic leukodystrophy, autosomal recessive. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. BP4 => Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.). BS3 => Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing (https://www.ncbi.nlm.nih.gov/pubmed/11941485) (https://www.ncbi.nlm.nih.gov/pubmed/2574462). |
Mendelics | RCV000020310 | SCV001141462 | likely benign | Metachromatic leukodystrophy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000020310 | SCV001733012 | benign | Metachromatic leukodystrophy | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000020310 | SCV001737289 | benign | Metachromatic leukodystrophy | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000078931 | SCV001871299 | benign | not provided | 2021-11-11 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 2574462, 21648305, 8897113, 30026549, 32437521, 26577183, 31670782, 32470555, 31312839, 31694723, 23581857) |
Breakthrough Genomics, |
RCV000078931 | SCV005207843 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000020310 | SCV000023349 | benign | Metachromatic leukodystrophy | 1997-12-01 | no assertion criteria provided | literature only | |
Gene |
RCV000020310 | SCV000040685 | not provided | Metachromatic leukodystrophy | no assertion provided | literature only | ||
Natera, |
RCV000020310 | SCV001456232 | benign | Metachromatic leukodystrophy | 2019-12-10 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001357207 | SCV001552597 | uncertain significance | Metachromatic leukodystrophy, juvenile type | no assertion criteria provided | clinical testing | ClinVar reports this variant as a Pseudodeficiency allele from ClinVar. Homozygosity for the p.Asn350Ser variant alone results in 50% or more of the mean control ARSA enzyme activity in leukocytes. Allele frequency is common in at least one population database (frequency: 39.478% in ExAC) based on the frequency threshold of 1.151% for this gene.Variant was observed in a homozygous state in population databases more than expected for disease.This variant is interpreted as Benign - Stand Alone, for Metachromatic leukodystrophy, autosomal recessive. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. BP4 => Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.). BS3 => Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing (https://www.ncbi.nlm.nih.gov/pubmed/11941485) (https://www.ncbi.nlm.nih.gov/pubmed/2574462). (ClinVar: SIB Swiss Institute of Bioinformatics) | |
Diagnostic Laboratory, |
RCV000249834 | SCV001740695 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000249834 | SCV001925236 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000249834 | SCV001931644 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000249834 | SCV001954847 | benign | not specified | no assertion criteria provided | clinical testing | ||
Gelb Laboratory, |
RCV000020310 | SCV005046796 | not provided | Metachromatic leukodystrophy | no assertion provided | in vitro |